AMY EGAN: Open Payments
NPI 1861702151 · WOODBURY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$835 in 33 payments from 9 companies in 2025. Trend: 2023 $202 · 2024 $335 · 2025 $835
Food & beverage: $835
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $289 |
| GlaxoSmithKline, LLC. | 16 | $233 |
| GENZYME CORPORATION | 5 | $185 |
| PFIZER INC. | 2 | $34 |
| BeOne Medicines USA, Inc. | 1 | $24 |
| Invivyd Inc | 1 | $18 |
| Viatris Specialty LLC | 1 | $18 |
| Verona Pharma, Inc. | 1 | $18 |
| JAZZ PHARMACEUTICALS INC. | 1 | $16 |
Products named: BREZTRI, NUCALA, DUPIXENT, FASENRA, PREVNAR 20, BRUKINSA, PEMGARDA, YUPELRI.
Industry payments across NJ — which companies pay providers there.
